Navigation Links
BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
Date:2/23/2009

MOUNTAIN VIEW, California, February 23 /PRNewswire/ -- BN ImmunoTherapeutics, Inc. today provided updated data from its clinical studies with its breast cancer vaccine, MVA-BN(R)-HER2, in development as therapy of metastatic breast cancer patients whose tumours over-express HER2. The study met its primary endpoint with regards to safety and by showing an immune response. Evidence of vaccine-induced anti-HER2 immune response was detected in approximately 70% of evaluated patients.

Clinically, the vaccine was well tolerated with no treatment-related severe adverse events. Currently, the disease has not progressed in 15 out of the 30 patients after a 6 month period. Also, in the group where vaccine was combined with chemotherapy, one complete response and one partial response were observed. These results confirm the positive interim data reported in 2008 and show that MVA-BN(R)-based, HER2 directed vaccination is a biologically active treatment for patients with HER2 positive breast cancer; however the overall immune response was moderate.

Additionally BN ImmunoTherapeutics has completed preclinical studies with an improved version of the MVA-BN(R)-HER2 vaccine. In those studies, the new vaccine induced up to 20-fold higher T-cell immune response as compared to the original version. Furthermore, it proved to be efficacious in additional tumour immunotherapy models in HER2 transgenic mice. The immunological situation regarding HER2 in those mice strongly resembles the situation in humans.

Based on those encouraging data from both clinical and preclinical studies BN ImmunoTherapeutics decided to advance the clinical development of MVA-BN(R)-HER2 in further clinical studies with the new and improved vaccine. Specifically, a new, single-site Phase I/II study in the US will be initiated by 2009 and evaluate 24 patients in both metastatic breast cancer as well as in an adjuvant therapy of breast can
'/>"/>

SOURCE BN ImmunoTherapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
2. BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
3. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
4. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
5. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
6. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
7. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
8. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
9. BioCryst Updates Peramivir Clinical Development Plan
10. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
11. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 Endo International plc (NASDAQ: ... revenues of $719 million, an increase of 1 percent ... Endo reported net income of $21 million in the ... million in the second quarter of 2013.  As detailed ... for the three months ended June 30, 2014 increased by ...
(Date:7/31/2014)... , 2014 Second Quarter Total Revenue $2.0 billion; an ... growth was 4% for same store sales and 8% pro ... 12% , 2014 Second Quarter GAAP EPS $0.37; Cash ... Quarter GAAP Operating Cash Flow $376 million; Adjusted Operating Cash ... Quarter , Launched 17 new products in the U.S. year-to-date ...
(Date:7/31/2014)... -- Today,s Consumer Reports story on prescription and non-prescription ... consumers of the importance of taking medicines safely ... the Acetaminophen Awareness Coalition,s (AAC) Know ... in 2010, the Coalition is a group of ... to educating consumers on safe acetaminophen use to ...
Breaking Medicine Technology:Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5
... 2011 Ventana Medical Systems, Inc . (Ventana), ... first-of-its-kind integration of the VIRTUOSO digital pathology software and ... integration to the anatomic pathology lab. The ... track the progress of a slide from preparation to ...
... 27, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: ... manufacturer and marketer of orthopedic implants in China, today announced ... Bank of America Merrill Lynch New China Conference to be ... JW Marriot Hotel in Beijing, China.  Management is scheduled to ...
Cached Medicine Technology:Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration 2Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration 3China Kanghui Holdings Announces Participation in Upcoming Investor Conferences 2
(Date:7/31/2014)... ProtonPACS, a division of Radsource, has ... Rural Health Association (NRHA), company officials announced today. The ... needs of rural health providers nationwide. , “We are ... said Dr. Mark Awh, President of Radsource. “While we ... we are also looking forward to learning from all ...
(Date:7/31/2014)... Boston, MA (PRWEB) July 31, 2014 Many ... fight for the weak, to correct injustices, and preserve the ... - action that can be lauded as crusading and exemplary ... the lawyer takes on corruption whose seed might be planted ... a fury and the ultimate punishment for an attorney - ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Computer Resources ... firm based in New York City, has been awarded ... the midtown Manhattan headquarters of a large global bank. ... investment banking. , Chico Ramnarayan, Chief Executive Officer of ... is an opportunity for us to further develop what ...
(Date:7/31/2014)... Loffler Companies, the leading business technology and ... Microsoft as a Microsoft Community Connections Partner of the ... 14, 2014. , The Microsoft U.S. SMB Champions ... cloud-based IT services and solutions to small and midsized ... SMB Champions Club member, Loffler has established a proven ...
(Date:7/31/2014)... 31, 2014 According to new ... Wheat, Mycoprotein), by Type (Tofu, Tofu-Based Product, Tempeh, ... - Global Trends & Forecasts to 2019", defines ... an analysis and forecasting of the market value ... The report also identifies the driving and restraining ...
Breaking Medicine News(10 mins):Health News:ProtonPACS Announces Pipeline Partnership with the National Rural Health Association. 2Health News:Supreme Court Press Petition of the Month for July 2014: Shutting Down Inconvenient Lawyers By Disbarment or Suspension 2Health News:Supreme Court Press Petition of the Month for July 2014: Shutting Down Inconvenient Lawyers By Disbarment or Suspension 3Health News:Global Bank Awards CRA with Network Infrastructure Contract 2Health News:Loffler Companies Named Microsoft Community Connections Partner of the Year Award Winner 2Health News:Loffler Companies Named Microsoft Community Connections Partner of the Year Award Winner 3Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 2Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 3
... by researchers at Wake Forest University Baptist Medical Center is ... weight loss in older adults leads to increased risk of ... intentionally exercised and/or modified their diets to lose weight were ... as their peers who did not work toward weight loss, ...
... give into your child,s meltdowns, expert says , SUNDAY, April ... have a hard time figuring out what to do when ... that kids often have their meltdowns in public places -- ... a Kansas State University child development expert, has compiled tips ...
... or more a week often quit their own jobs, researchers say ... more than 60 hours a week, watch out: His commitment ... , A new study finds that women with husbands who work ... expected to pick up the slack at home in regard to ...
... The law firm of Dussault ... $90,000.00 , ... 2, 2010 -- The law firm of Dussault and Zatir settled out of court a claim ... 92-year-old woman, while walking in her yard, was knocked to the ground by a neighbor’s dog. ...
... ... ... Passover and Easter, a New Jersey physician ventured into the bush country of Haiti. , ... N.J. resident, left at 4 a.m. on Friday, April 2, for a week-long medical mission ...
... tie-in to tremors and other motor problems , ... how a mutation in a gene called LRRK2 may ... , In experiments using genetically engineered mice, the Mount ... dopamine transmission and controls motor performance. Dopamine is a ...
Cached Medicine News:Health News:Belief that intentional weight loss is harmful to seniors is unfounded 2Health News:Belief that intentional weight loss is harmful to seniors is unfounded 3Health News:Dealing With Those All-Too-Public Tantrums 2Health News:Working Wives Still Expected to Do It All, Study Finds 2Health News:NJ Medical Director Travels To Haiti's Bush Country 2Health News:NJ Medical Director Travels To Haiti's Bush Country 3
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
... This remarkable anti-reflux valve is ... housing which prevents the valve ... when in sitting or reclining ... self-cleaning and interference free ensuring ...
... AggRAM, for platelet aggregation and ristocetin ... with the power of Windows-based software ... to two AggRAM modules can be ... computer so you can configure your ...
The Multiple Perfusion set provides simultaneous perfusion of the aortic root and up to three or more vein grafts. The set features an inlet port with female luer and clamp attached to an adapter whi...
Medicine Products: